Abstract
Violacein is a tryptophan-derived purple pigment produced by environmental bacteria, which displays multiple biological activities, including strong inhibition of Gram-positive pathogens. Here, we applied a combination of experimental approaches to identify the mechanism by which violacein kills Gram-positive bacteria. Fluorescence microscopy showed that violacein quickly and dramatically permeabilizes B. subtilis and S. aureus cells. Cell permeabilization was accompanied by the appearance of visible discontinuities or rips in the cytoplasmic membrane, but it did not affect the cell wall. Using in vitro experiments, we showed that violacein binds directly to liposomes made with commercial and bacterial phospholipids and perturbs their structure and permeability. Furthermore, molecular dynamics simulations were employed to reveal how violacein inserts itself into lipid bilayers. Thus, our combined results demonstrate that the cytoplasmic membrane is the primary target of violacein in bacteria. The implications of this finding for the development of violacein as a therapeutic agent are discussed.
Originalsprog | Engelsk |
---|---|
Tidsskrift | ACS infectious diseases |
Vol/bind | 5 |
Udgave nummer | 4 |
Sider (fra-til) | 539-549 |
Antal sider | 11 |
ISSN | 2373-8227 |
DOI | |
Status | Udgivet - 2019 |
Udgivet eksternt | Ja |
Bibliografisk note
Funding Information:This work was supported by FAPESP grants 2016/05203-5 to F.J.G.-F., 2012/20116-0 to M.B, and 2013/08166-5 to I.M.C. and the following fellowships: CAPES PhD fellowship 1521952 to A.C.G.C.; National Institute of Science and Technology Complex Fluids (INCT-FCx) CAPES postdoctoral fellowship 88887.137085/2017-00 to G.P.B.C.; Proj. Biocomputacional CAPES postdoctoral fellowship 23038.004630/2017-35 to G.K.V.S.; CNPq PhD fellowship 141260/2017-3 to P.P.; CNPq PhD fellowship 141867/2017-5 to L.M. Research was developed with HPC resources from the Superintende.ncia de Tecnologia da Informac.a.o of Universidade de Sa.o Paulo.
Funding Information:
Biocomputacional CAPES postdoctoral fellowship 23038.004630/2017-35 to G.K.V.S.; CNPq PhD fellowship 141260/2017-3 to P.P.; CNPq PhD fellowship 141867/2017-5 to L.M. Research was developed with HPC resources from the Superintendenciâ de Tecnologia da Informaca̧ õ of Universi-dade de Saõ Paulo. We thank André Pulschen and Diego Sastre for help with fluorescence microscopy and lipid extraction from bacterial cultures and Andrea Dessen for reading the manuscript.
Emneord
- daptomycin
- mechanism of action
- membrane disruption
- membrane-active agent
- Staphylococcus aureus
- violacein